Alpha-1 Antitrypsin Clinical Practice Guidelines
CPD Hours / Duration
1 hour/s
Depends on Membership level

Alpha-1 Antitrypsin Clinical Practice Guidelines

Presenter The Nursing CPD Institute

AATD is a rare genetic condition estimated to effect approximately 1 in 300 people in Australia. Early symptoms are often misdiagnosed as asthma, with an accurate diagnosis often taking several years.

Course Content

Alpha-1 Antitrypsin deficiency (AATD) is a genetic condition that may result in lung and/or liver disease. Alpha-1 Antitrypsin is a protein whose primary function is to protect the lungs from neutrophil disease.

Target Audience

Learning Outcomes

In this session, you will:

  • Review the recommended Clinical Practice Guidelines for Alpha-1
  • Define Alpha-1 Antitrypsin Deficiency
  • Understand the challenges of diagnosis & treatment for Alpha-1 patients
  • Acquire knowledge about the recommended treatment pathways for Alpha-1 patients